Alnylam Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02043Q1076
USD
219.20
3.08 (1.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlnylam Pharmaceuticals, Inc. VS Pharmaceuticals & Biotechnology
 
1D
1.43%
0.62%
1W
6.66%
3.58%
1M
-31.84%
3.38%
YTD
-44.88%
13.32%
1Y
-49.62%
22.36%
3Y
18.94%
71.69%
5Y
12.28%
74.86%
10Y
179.52%
255.39%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.92%
0%
-25.92%
6 Months
-33.2%
0%
-33.2%
1 Year
-49.62%
0%
-49.62%
2 Years
-15.75%
0%
-15.75%
3 Years
18.94%
0%
18.94%
4 Years
0.28%
0%
0.28%
5 Years
12.28%
0%
12.28%

Alnylam Pharmaceuticals, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary